Primo Biotechnology Co., Ltd.

About Primo Biotechnology Co., Ltd.

Primo Biotechnology is focused on disruptive innovation in cancer management through molecular image-guided and targeted diagnosis and therapy. The company aims to lead in precision radiopharmaceutical approaches for the diagnosis and treatment of cancer.

Products & Services

Lu-177 Ilumira:An isotope-based product for cancer treatment.

Radioligand Theranostics:Advanced radiopharmaceuticals designed as precision theranostics for cancers.

Pre-clinical Studies:Research services including specific animal models and in-vivo animal imaging, supporting the development of small-molecule drugs and therapeutic antibodies.

CRO/CDMO of Radiopharmaceuticals:One-stop and customized services including scientific consulting, technical support, and regulatory applications for clinical trials using common or novel radiopharmaceuticals.

Specialties

Precision Radiopharmaceuticals Molecular Image-Guided Diagnosis and Therapy Radioligand Theranostics Pre-clinical Research CRO/CDMO Services

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 6875000 MR: - FA: NT$220 million FAN: 6875000	D: 2025-07-02 FD: 2025-07-02	-

Series A Latest

2025-07-02

$6.9M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joe Yeh

Founder & Chairman

Y

Ya-Yao Huang

Founder & CEO

C

Chi-Wei Chang

CTO of Radiopharmaceutical Chemistry

Y

Ya-Ting Huang

Director of Research and Development

C

Camus Wu

Application Manager

S

Sunny Chen

Marketing Manager

View 4 more team members with Pro

Unlock Full Team Directory

Recent News